Insiders Xenon Pharmaceuticals Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 12:22:15 2024-06-11 pm EDT			5-day change	1st Jan Change
37.63 ^USD	-1.60%		-1.34%	-18.39%

Jun. 04	Transcript : Xenon Pharmaceuticals Inc. - Shareholder/Analyst Call
May. 28	Xenon Pharmaceuticals Inc. Presents Data from Phase 2 X-Nova Clinical Trial of Azetukalner in Major Depressive Disorder At the American Society of Clinical Psychopharmacology 2024 Annual Meeting	CI

Xenon Pharmaceuticals Inc. Announces Board Resignations	Apr. 19	CI
Xenon Pharmaceuticals Insider Sold Shares Worth $330,290, According to a Recent SEC Filing	Mar. 08	MT
Xenon Pharmaceuticals Insider Sold Shares Worth $601,615, According to a Recent SEC Filing	Mar. 08	MT
Xenon Pharmaceuticals Insider Sold Shares Worth $758,983, According to a Recent SEC Filing	Dec. 15	MT
Insider Sell: Xenon Pharmaceuticals	23-08-24	MT
Xenon Pharmaceuticals Inc. Announces Board Appointments	23-08-08	CI
Insider Sell: Xenon Pharmaceuticals	23-05-30	MT
Xenon Pharmaceuticals Inc. Announces Appointment of Andrea Difabio as Chief Legal Officer and Corporate Secretary	22-11-07	CI
Insider Sell: Xenon Pharmaceuticals	22-09-07	MT
Insider Sell: Xenon Pharmaceuticals	22-09-02	MT
Insider Sell: Xenon Pharmaceuticals	22-08-16	MT
Insider Sell: Xenon Pharmaceuticals	22-08-16	MT
Xenon Pharmaceuticals Inc. Announces Michael Hayden Will Not Stand for Re-Election as Member of Board	22-06-01	CI
Insider Sell: Xenon Pharmaceuticals	22-03-09	MT
Insider Sell: Xenon Pharmaceuticals	22-03-09	MT
Insider Sell: Xenon Pharmaceuticals	22-03-09	MT
Xenon Pharmaceuticals Inc. Appoints Christopher Kenney, M.D. as Chief Medical Officer	21-08-23	CI
Xenon Pharmaceuticals Inc. Announces Board Appointments	21-06-03	CI
Xenon Pharmaceuticals Inc Elects Ian Mortimer as Chief Executive Officer	21-06-03	CI
Insider Trends: Xenon Pharmaceuticals Insider Converts/Exercises Derivative Security, Sells for Taxes and Self, Buying Trend Remains Intact	21-06-01	MT

No results for this search